Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-010738
Filing Date
2025-05-15
Accepted
2025-05-15 14:36:27
Documents
1
Period of Report
2025-04-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2188
  Complete submission text file 0001641172-25-010738.txt   3813
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address B-11-03 FRASER TOWERS JALAN 5/60 PETALING JAYA SELANGOOR Malaysia 46000
Business Address
Ho Kee Wee (Reporting) CIK: 0002068629 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 25951530